{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,1,13]],"date-time":"2026-01-13T15:53:31Z","timestamp":1768319611146,"version":"3.49.0"},"reference-count":22,"publisher":"Springer Science and Business Media LLC","issue":"8","license":[{"start":{"date-parts":[[2007,1,13]],"date-time":"2007-01-13T00:00:00Z","timestamp":1168646400000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Clin Rheumatol"],"published-print":{"date-parts":[[2007,6,27]]},"DOI":"10.1007\/s10067-006-0507-8","type":"journal-article","created":{"date-parts":[[2007,1,12]],"date-time":"2007-01-12T09:33:02Z","timestamp":1168594382000},"page":"1320-1327","source":"Crossref","is-referenced-by-count":34,"title":["Efficacy prediction of cevimeline in patients with Sj\u00f6gren\u2019s syndrome"],"prefix":"10.1007","volume":"26","author":[{"given":"Hiroyuki","family":"Yamada","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yoichi","family":"Nakagawa","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ei","family":"Wakamatsu","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Takayuki","family":"Sumida","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Shigeo","family":"Yamachika","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yoshiaki","family":"Nomura","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Kenji","family":"Mishima","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ichiro","family":"Saito","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2007,1,13]]},"reference":[{"key":"507_CR1","doi-asserted-by":"crossref","first-page":"391","DOI":"10.1016\/S0889-857X(21)00055-7","volume":"20","author":"RI Fox","year":"1994","unstructured":"Fox RI, Saito I (1994) Criteria for diagnosis of Sj\u00f6gren\u2019s syndrome. Rheum Dis Clin North Am 20:391\u2013407","journal-title":"Rheum Dis Clin North Am"},{"key":"507_CR2","doi-asserted-by":"crossref","first-page":"241","DOI":"10.1159\/000077761","volume":"38","author":"PC Fox","year":"2004","unstructured":"Fox PC (2004) Salivary enhancement therapies. Caries Res 38:241\u2013246","journal-title":"Caries Res"},{"key":"507_CR3","first-page":"315","volume":"328","author":"Y Iwabuchi","year":"1994","unstructured":"Iwabuchi Y, Katagiri M, Masuhara T (1994) Salivary secretion and histopathological effects after single administration of the muscarinic agonist SNI-2011 in MRL\/lpr mice. Arch Int Pharmacodyn Ther 328:315\u2013325","journal-title":"Arch Int Pharmacodyn Ther"},{"key":"507_CR4","doi-asserted-by":"crossref","first-page":"1293","DOI":"10.1001\/archinte.162.11.1293","volume":"162","author":"RS Fife","year":"2002","unstructured":"Fife RS, Chase WF, Dore RK, Wiesenhutter CW, Lockhart PB, Tindall E, Suen JY (2002) Cevimeline for the treatment of xerostomia in patients with Sj\u00f6gren syndrome: a randomized trial. Arch Intern Med 162:1293\u20131300","journal-title":"Arch Intern Med"},{"key":"507_CR5","doi-asserted-by":"crossref","first-page":"748","DOI":"10.1002\/art.510","volume":"46","author":"D Petrone","year":"2002","unstructured":"Petrone D, Condemi JJ, Fife R, Gluck O, Cohen S, Dalgin P (2002) A double-blind, randomized, placebo-controlled study of cevimeline in Sj\u00f6gren\u2019s syndrome patients with xerostomia and keratoconjunctivitis sicca. Arthritis Rheum 46:748\u2013754","journal-title":"Arthritis Rheum"},{"key":"507_CR6","doi-asserted-by":"crossref","first-page":"2615","DOI":"10.1002\/art.20371","volume":"50","author":"J Gao","year":"2004","unstructured":"Gao J, Cha S, Jonsson R, Opalko J, Peck AB (2004) Detection of anti-type 3 muscarinic acetylcholine receptor autoantibodies in the sera of Sj\u00f6gren\u2019s syndrome patients by use of a transfected cell line assay. Arthritis Rheum 50:2615\u20132621","journal-title":"Arthritis Rheum"},{"key":"507_CR7","doi-asserted-by":"crossref","first-page":"1165","DOI":"10.1002\/art.21764","volume":"54","author":"LJ Dawson","year":"2006","unstructured":"Dawson LJ, Stanbury J, Venn N, Hasdimir B, Rogers SN, Smith PM (2006) Antimuscarinic antibodies in primary Sj\u00f6gren\u2019s syndrome reversibly inhibit the mechanism of fluid secretion by human submandibular salivary acinar cells. Arthritis Rheum 54:1165\u20131173","journal-title":"Arthritis Rheum"},{"key":"507_CR8","doi-asserted-by":"crossref","first-page":"425","DOI":"10.3109\/s10165-004-0338-x","volume":"14","author":"T Fujibayashi","year":"2004","unstructured":"Fujibayashi T, Sugai S, Miyasaka N, Hayashi Y, Tsubota K (2004) Revised Japanese criteria for Sj\u00f6gren\u2019s syndrome (1999): availability and validity. Mod Rheumatol 14:425\u2013434","journal-title":"Mod Rheumatol"},{"key":"507_CR9","doi-asserted-by":"crossref","first-page":"554","DOI":"10.1136\/ard.61.6.554","volume":"61","author":"C Vitali","year":"2002","unstructured":"Vitali C, Bombardieri S, Jonsson R, Moutsopoulos HM, Alexander EL, Carsons SE, Daniels TE, Fox PC, Fox RI, Kassan SS, Pillemer SR, Talal N, Weisman MH (2002) Classification criteria for Sj\u00f6gren\u2019s syndrome: a revised version of the European criteria proposed by the American-European Consensus Group. Ann Rheum Dis 61:554\u2013558","journal-title":"Ann Rheum Dis"},{"key":"507_CR10","first-page":"575","volume":"77","author":"P Rubin","year":"1957","unstructured":"Rubin P, Holt JF (1957) Secretory sialography in diseases of the major salivary glands. Am J Roentgenol Radium Ther Nucl Med 77:575\u2013598","journal-title":"Am J Roentgenol Radium Ther Nucl Med"},{"key":"507_CR11","doi-asserted-by":"crossref","first-page":"217","DOI":"10.1016\/0030-4220(74)90417-4","volume":"37","author":"JS Greenspan","year":"1974","unstructured":"Greenspan JS, Daniels TE, Talal N, Sylvester RA (1974) The histopathology of Sj\u00f6gren\u2019s syndrome in labial salivary gland biopsies. Oral Surg Oral Med Oral Pathol 37:217\u2013229","journal-title":"Oral Surg Oral Med Oral Pathol"},{"key":"507_CR12","doi-asserted-by":"crossref","first-page":"510","DOI":"10.1136\/ard.2004.025478","volume":"64","author":"Y Naito","year":"2005","unstructured":"Naito Y, Matsumoto I, Wakamatsu E, Goto D, Sugiyama T, Matsumura R, Ito S, Tsutsumi A, Sumida T (2005) Muscarinic acetylcholine receptor autoantibodies in patients with Sj\u00f6gren\u2019s syndrome. Ann Rheum Dis 64:510\u2013511","journal-title":"Ann Rheum Dis"},{"key":"507_CR13","doi-asserted-by":"crossref","first-page":"670","DOI":"10.1093\/rheumatology\/41.6.670","volume":"41","author":"J Rosas","year":"2002","unstructured":"Rosas J, Ramos-Casals M, Ena J, Garcia-Carrasco M, Verdu J, Cervera R, Font J, Caballero O, Ingelmo M, Pascual E (2002) Usefulness of basal and pilocarpine-stimulated salivary flow in primary Sj\u00f6gren\u2019s syndrome. Correlation with clinical, immunological and histological features. Rheumatology (Oxford) 41:670\u2013675","journal-title":"Rheumatology (Oxford)"},{"key":"507_CR14","doi-asserted-by":"crossref","first-page":"174","DOI":"10.1001\/archinte.159.2.174","volume":"159","author":"FB Vivino","year":"1999","unstructured":"Vivino FB, Al-Hashimi I, Khan Z, LeVeque FG, Salisbury PL III, Tran-Johnson TK, Muscoplat CC, Trivedi M, Goldlust B, Gallagher SC (1999) Pilocarpine tablets for the treatment of dry mouth and dry eye symptoms in patients with Sj\u00f6gren syndrome: a randomized, placebo-controlled, fixed-dose, multicenter trial. P92-01 Study Group. Arch Intern Med 159:174\u2013181","journal-title":"Arch Intern Med"},{"key":"507_CR15","doi-asserted-by":"crossref","first-page":"169","DOI":"10.1097\/01.rhu.0000135553.08057.21","volume":"10","author":"AS Papas","year":"2004","unstructured":"Papas AS, Sherrer YS, Charney M, Golden HE, Medsger TA Jr, Walsh BT, Trivedi M, Goldlust B, Gallagher SC (2004) Successful treatment of dry mouth and dry eye symptoms in Sj\u00f6gren\u2019s syndrome patients with oral pilocarpine: a randomized, placebo-controlled, dose-adjustment study. J Clin Rheumatol 10:169\u2013177","journal-title":"J Clin Rheumatol"},{"key":"507_CR16","first-page":"561","volume":"16","author":"R Matsumura","year":"1998","unstructured":"Matsumura R, Umemiya K, Kagami M, Tomioka H, Tanabe E, Sugiyama T, Sueishi M, Nakajima A, Azuma M, Okumura K, Sumida T (1998) Glandular and extraglandular expression of the Fas\u2013Fas ligand and apoptosis in patients with Sj\u00f6gren\u2019s syndrome. Clin Exp Rheumatol 16:561\u2013568","journal-title":"Clin Exp Rheumatol"},{"key":"507_CR17","doi-asserted-by":"crossref","first-page":"305","DOI":"10.1038\/sj.bdj.4807861","volume":"172","author":"WM Edgar","year":"1992","unstructured":"Edgar WM (1992) Saliva: its secretion, composition and functions. Br Dent J 172:305\u2013312","journal-title":"Br Dent J"},{"key":"507_CR18","doi-asserted-by":"crossref","first-page":"675","DOI":"10.1016\/0030-4220(91)90009-2","volume":"72","author":"T Saito","year":"1991","unstructured":"Saito T, Fukuda H, Arisue M, Matsuda A, Shindoh M, Amemiya A, Ohmori K (1991) Relationship between sialographic findings of parotid glands and histopathologic finding of labial glands in Sj\u00f6gren\u2019s syndrome. Relation to clinical and immunologic findings. Oral Surg Oral Med Oral Pathol 72:675\u2013680","journal-title":"Oral Surg Oral Med Oral Pathol"},{"key":"507_CR19","doi-asserted-by":"crossref","first-page":"7538","DOI":"10.1073\/pnas.95.13.7538","volume":"95","author":"CP Robinson","year":"1998","unstructured":"Robinson CP, Brayer J, Yamachika S, Esch TR, Peck AB, Stewart CA, Peen E, Jonsson R, Humphreys-Beher MG (1998) Transfer of human serum IgG to nonobese diabetic Igmu null mice reveals a role for autoantibodies in the loss of secretory function of exocrine tissues in Sj\u00f6gren\u2019s syndrome. Proc Natl Acad Sci USA 95:7538\u20137543","journal-title":"Proc Natl Acad Sci USA"},{"key":"507_CR20","doi-asserted-by":"crossref","first-page":"245","DOI":"10.1006\/clin.1996.0036","volume":"78","author":"H Yamamoto","year":"1996","unstructured":"Yamamoto H, Sims NE, Macauley SP, Nguyen KH, Nakagawa Y, Humphreys-Beher MG (1996) Alterations in the secretory response of non-obese diabetic (NOD) mice to muscarinic receptor stimulation. Clin Immunol Immunopathol 78:245\u2013255","journal-title":"Clin Immunol Immunopathol"},{"key":"507_CR21","doi-asserted-by":"crossref","first-page":"2297","DOI":"10.1002\/1529-0131(200010)43:10<2297::AID-ANR18>3.0.CO;2-X","volume":"43","author":"KH Nguyen","year":"2000","unstructured":"Nguyen KH, Brayer J, Cha S, Diggs S, Yasunari U, Hilal G, Peck AB, Humphreys-Beher MG (2000) Evidence for antimuscarinic acetylcholine receptor antibody-mediated secretory dysfunction in nod mice. Arthritis Rheum 43:2297\u20132306","journal-title":"Arthritis Rheum"},{"key":"507_CR22","first-page":"26","volume":"53","author":"T Washio","year":"2003","unstructured":"Washio T, Kohsaka K, Arisawa H, Masunaga H (2003) Pharmacokinetics and metabolism of the novel muscarinic receptor agonist SNI-2011 in rats and dogs. Arzneimittelforschung 53:26\u201333","journal-title":"Arzneimittelforschung"}],"container-title":["Clinical Rheumatology"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s10067-006-0507-8.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1007\/s10067-006-0507-8\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s10067-006-0507-8","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2021,8,7]],"date-time":"2021-08-07T15:14:48Z","timestamp":1628349288000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/s10067-006-0507-8"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2007,1,13]]},"references-count":22,"journal-issue":{"issue":"8","published-print":{"date-parts":[[2007,6,27]]}},"alternative-id":["507"],"URL":"https:\/\/doi.org\/10.1007\/s10067-006-0507-8","relation":{},"ISSN":["0770-3198","1434-9949"],"issn-type":[{"value":"0770-3198","type":"print"},{"value":"1434-9949","type":"electronic"}],"subject":[],"published":{"date-parts":[[2007,1,13]]}}}